Total Neoadjuvant Therapy With Additional Consolidation Chemotherapy Followed by Local Excision Versus Total Neoadjuvant Therapy Followed by Local Excision at Stage I Rectal Cancer

Clinical trial NCT07563907 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07563907
Sponsor: Seoul National University Hospital
Status: NOT_YET_RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Organ Preservation Rectal Cancer Stage I Total Neoadjuvant Treatment Consolidation Therapy Capecitabine

Start date: 2026-06-01
Primary completion: 2030-12-31
Enrollment: 292

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.